About the GSK Clinical Study Register
The GlaxoSmithKline (GSK) Clinical Study Register provides an easily accessible repository of data from GSK-Sponsored Clinical Studies, supplementing communication in journals, at scientific meetings, in letters to healthcare professionals, and in approved prescribing information. It is important to emphasise that approved prescribing information must continue to guide appropriate use of GSK medicines. This information may vary from country to country. Before prescribing any product mentioned in the Register, Healthcare Professionals should consult prescribing information approved in their country.
- Protocol Summaries
- Scientific Result Summaries
- Clinical Study Report
- Patient Level Data
GSK Alliance Companies
GSK has many alliances with other pharmaceutical companies. As part of these alliances, GSK may not have been the regulatory sponsor of all clinical studies for a product and therefore the results of such studies may not appear on this register. Please see other public registries such as www.ClinicalTrials.gov or EU Clinical Trials Register for any study disclosures from our alliance companies.
For more information on this register please call +1.877.379.3718
GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.
IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).
This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.
EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.